Alerts will be sent to your verified email
Verify EmailACCPL
Accretion Pharma.
|
Sakar Healthcare
|
Lincoln Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
72.47 % | 9.28 % | 15.94 % |
5yr average Equity Multiplier
|
5.06 | 1.75 | 1.3 |
5yr Average Asset Turnover Ratio
|
1.24 | 0.5 | 0.84 |
5yr Avg Net Profit Margin
|
11.51 % | 10.38 % | 14.61 % |
Price to Book
|
0.0 | 2.43 | 1.89 |
P/E
|
0.0 | 39.6 | 13.5 |
5yr Avg Cash Conversion Cycle
|
108.78 Days | -14.29 Days | 24.49 Days |
Inventory Days
|
156.95 Days | 46.75 Days | 42.89 Days |
Days Receivable
|
62.93 Days | 51.16 Days | 90.22 Days |
Days Payable
|
111.1 Days | 103.34 Days | 111.35 Days |
5yr Average Interest Coverage Ratio
|
5.99 | 5.43 | 58.2 |
5yr Avg ROCE
|
55.84 % | 10.08 % | 20.48 % |
5yr Avg Operating Profit Margin
|
22.25 % | 24.06 % | 18.48 % |
5 yr average Debt to Equity
|
2.52 | 0.47 | 0.0 |
5yr CAGR Net Profit
|
117.34 % | 3.94 % | 12.65 % |
5yr Average Return on Assets
|
14.33 % | 5.37 % | 12.28 % |
Shareholdings
|
|||
Promoter Holding
|
n/a | 53.58 % | 49.78 % |
Share Pledged by Promoters
|
n/a | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
n/a | -13.96 % | 7.73 % |
Change in Mutual Fund Holding (3 Yrs)
|
n/a | 0.0 | 0.0 |
Accretion Pharma.
|
Sakar Healthcare
|
Lincoln Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|